The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Open accessAbstract
OBJECTIVE: Studies of subjects with dementia of the Alzheimer type have reported correlations between increases in activity of the hypothalamic-pituitary-adrenal (HPA) axis and hippocampal degeneration. In this study, the authors sought to determine whether increases in plasma cortisol, a marker of HPA activity, were associated with clinical and cognitive measures of the rate of disease progression in subjects with Alzheimer-type dementia. METHOD: Thirty-three subjects with very mild and mild Alzheimer-type dementia and 21 subjects without dementia were assessed annually for up to 4 years with the Clinical Dementia Rating scale and a battery of neuropsychological tests. Plasma was obtained at 8 a.m. on a single day and assayed for cortisol. Rates of change over time in the clinical and cognitive measures were derived from growth curve models. RESULTS: In the subjects with dementia, but not in those without dementia, higher plasma cortisol levels were associated with more rapidly increasing symptoms of dementia and more rapidly decreasing performance on neuropsychological tests associated with temporal lobe function. No associations were observed between plasma cortisol levels and clinical and cognitive assessments obtained at the single assessment closest in time to the plasma collection. CONCLUSIONS: Higher HPA activity, as reflected by increased plasma cortisol levels, is associated with more rapid disease progression in subjects with Alzheimer-type dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · cited 1×
“Also, because of suggested links between hypercortisolemia and depression in the elderly (5), symptoms of depression were assessed with the Geriatric Depression Scale at the time of the annual assessments (35).”
MethodThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationRandom-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Di Rosa, E., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,453
An active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Self-citationMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Self-citationMcEwen, B. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02950-4 · Cited by 1,827
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212 · cited 1×
“the cornu ammonis of the hippocampus (3) and deficits in”
BackgroundGrundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Malberg, J. E., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300234 · Cited by 815
(1992) · Cited by 777
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1998) · Neurology · doi:10.1212/wnl.51.4.993 · Cited by 666
Basal cortisol levels and cognitive deficits in human aging
Lupien, S., Lecours, A., Lussier, I., Schwartz, G., Nair, N., & Meaney, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02893.1994 · Cited by 566 · cited 1×
“More recently, correlations have been reported between increased plasma cortisol levels, memory impairments, and smaller hippocampal volumes in nondemented elderly subjects (15, 16).”
BackgroundHippocampal Aging and Adrenocorticoids: Quantitative Correlations
Landfield, P. W., Waymire, J. C., & Lynch, G. (1978) · Science · doi:10.1126/science.715460 · Cited by 489
Issa, A., Rowe, W., Gauthier, S., & Meaney, M. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03247.1990 · Cited by 435
Sánchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04657.2000 · Cited by 420
Morris, J. C., Ernesto, C., Schafer, K., Coats, M., Leon, S., Sano, M., Thal, L. J., & Woodbury, P. (1997) · Neurology · doi:10.1212/wnl.48.6.1508 · Cited by 377
Self-citationLowy, M. T., Gault, L., & Yamamoto, B. K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09839.x · Cited by 344
Dong, H., Goico, B., Martin, M., Csernansky, C. A., Bertchume, A., & Csernansky, J. G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.040 · Cited by 342 · cited 1×
“org and memory that usually accompany β−amyloid deposition (45).”
BackgroundSelf-citationReliability of the Washington University Clinical Dementia Rating
Burke, W. J., Miller, J. P., Rubin, E. H., Morris, J. C., Coben, L. A., Duchek, J., Wittels, I. G., & Berg, L. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520250037015 · Cited by 326
Self-citationVenero, C., & Borrell, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00668.x · Cited by 277
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
Wang, L., Swank, J. S., Glick, I. E., Gado, M. H., Miller, M. I., Morris, J. C., & Csernansky, J. G. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00361-6 · Cited by 263
Self-citationGlucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain
Patel, P. D., Lopez, J. F., Lyons, D. M., Burke, S., Wallace, M., & Schatzberg, A. F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00035-2 · Cited by 252
Cortisol and Alzheimer's disease, I: Basal studies
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.3.300 · Cited by 246
Rates of progression in mild cognitive impairment and early Alzheimer’s disease
Storandt, M., Grant, E. A., Miller, J. P., & Morris, J. C. (2002) · Neurology · doi:10.1212/wnl.59.7.1034 · Cited by 202
Self-citationGiesbrecht, F. G., & Burns, J. C. (1985) · Biometrics · doi:10.2307/2530872 · Cited by 199
ABNORMAL CORTISOL RESPONSE IN ALZHEIMER'S DISEASE LINKED TO HIPPOCAMPAL ATROPHY
De Leon, M., Mcrae, T., Tsai, J., George, A., Marcus, D., Freedman, M., Wolf, A., & Mcewen, B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92855-3 · Cited by 198
Mild senile dementia of the alzheimer type: 2. Longitudinal assessment
Berg, L., Miller, J. P., Storandt, M., Duchek, J., Morris, J. C., Rubin, E. H., Burke, W. J., & Coben, L. A. (1988) · Annals of Neurology · doi:10.1002/ana.410230509 · Cited by 187
Self-citationO'Brien, J. T., Ames, D., Schweitzer, I., Colman, P., Desmond, P., & Tress, B. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.6.679 · Cited by 173
Longitudinal study of basal cortisol levels in healthy elderly subjects: Evidence for subgroups
Lupien, S., Lecours, A., Schwartz, G., Sharma, S., Hauger, R. L., Meaney, M. J., & Nair, N. P. V. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02005-5 · Cited by 173
Stress, glucocorticoids and structural plasticity of the hippocampus
Fuchs, E., & Flügge, G. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00031-1 · Cited by 172
Swanwick, G., Kirby, M., Bruce, I., Buggy, F., Coen, R. F., Coakley, D., & LAWLOR, B. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.286 · Cited by 137
Coburn-Litvak, P. S., Pothakos, K., Tata, D. Α., McCloskey, D. P., & Anderson, B. J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00019-4 · Cited by 136
Weiland, N. G., Orchinik, M., & Tanapat, P. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00619-7 · Cited by 129
Cortisol Secretion and Alzheimer’s Disease Progression
Weiner, M., Vobach, S., Olsson, K., Svetlik, D. A., & Risser, R. C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00165-0 · Cited by 129
Kanne, S., Balota, D. A., Storandt, M., McKeel, D. W., & Morris, J. C. (1998) · Neurology · doi:10.1212/wnl.50.4.979 · Cited by 121
Self-citationIncreased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease
Rasmuson, S., Näsman, B., Carlström, K., & Olsson, T. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048637 · Cited by 113
Glucocorticoids and the ageing hippocampus
Hibberd, C. J., Yau, J. L. W., & Seckl, J. R. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19740553.x · Cited by 113
Umegaki, H., Ikari, H., Nakahata, H., Endo, H., Suzuki, Y., Ogawa, O., Nakamura, A., Yamamoto, T., & Iguchi, A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02847-x · Cited by 110
Central and Peripheral Endorphins: Basic and Clinical Aspects
Davis, G. C. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.5.664-a · Cited by 91
Neuropeptide Abnormalities in Patients With Early Alzheimer Disease
Davis, K. L., Mohs, R. C., Marin, D. B., Purohit, D. P., Perl, D. P., Lantz, M., Austin, G., & Haroutunian, V. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.981 · Cited by 86
Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone
Belanoff, J. K., Jurik, J., Schatzberg, L. D., DeBattista, C., & Schatzberg, A. F. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0033-3 · Cited by 63
Miller, T. P., Taylor, J. L., Rogerson, S., Mauricio, M., Kennedy, Q., Schatzberg, A. F., Tinklenberg, J. R., & Yesavage, J. A. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005171 · Cited by 57
Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Aβ clearance in vitro and in vivo
Harris‐White, M. E., Chu, T., Miller, S., Simmons, M., Teter, B., Nash, D., Cole, G. M., & Frautschy, S. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00051-1 · Cited by 53
Mifepristone (RU 486) for Alzheimer’s disease
Pomara, N., Doraiswamy, P. M., Tun, H., & Ferris, S. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1436 · Cited by 52
Pryce, C. R., Feldon, J., Fuchs, E., Knuesel, I., Oertle, T., Sengstag, C., Spengler, M., Weber, E., Weston, A. A., & Jongen‐Rêlo, A. L. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04003.x · Cited by 49
Cortical and subcortical neuropeptides in Alzheimer's disease
Auchus, A. P., Green, R. C., & Nemeroff, C. B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90102-3 · Cited by 22
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Research works printed but not linked: 2
- 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- Littell R, 1996, Wolfinger R: SAS System for Mixed Models
Cited by
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Religion, Spirituality, and Health: The Research and Clinical Implications
Koenig, H. G. (2012) · ISRN Psychiatry · doi:10.5402/2012/278730 · Cited by 2,423
“Physiological chan-ges that occur with stress and depression (elevated blood cortisol, in particular) are known to adversely a ff ect the parts of the brain responsible for memory [419–421].”
BackgroundEffects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
“For patients in the early stages of AD, cortisol levels are markedly elevated relative to agematched nondemented adults,(66-70) and higher levels among patients predict more rapid disease progression.(71) Hypothalamic-pituitary-adrenal axis overactivity may ultimately compromise brain resilience to stress, increasing…”
Chronic stress, cognitive functioning and mental health
Marin, M.-F., Lord, C., Andrews, J., Juster, R.-P., Sindi, S., Arsenault-Lapierre, G., Fiocco, A. J., & Lupien, S. J. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.016 · Cited by 654
Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
Self-citation
Metadata
- Authors
- Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C.
- Venue
- American Journal of Psychiatry
- Published
- 2006-12
- Volume
- 163
- Issue
- 12
- Pages
- 2164-2169
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2079409065
- Cited by
- 426
- References
- 54
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.